| Net Cash Provided by (Used in) Operating Activities |
$12,201,000 |
USD |
6.9% |
Q3 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$185,000 |
USD |
96% |
Q3 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
175,000,000 |
shares |
40% |
Q3 2024 |
Q1 2025 |
| Common Stock, Shares, Issued |
154,590,918 |
shares |
113% |
Q3 2024 |
Q1 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$12,061,000 |
USD |
-53% |
Q3 2024 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$94,275,000 |
USD |
62% |
Q2 2024 |
FY 2024 |
| Operating Lease, Liability |
$854,000 |
USD |
-35% |
Q3 2024 |
Q1 2025 |
| Depreciation |
$8,200,000 |
USD |
-14% |
Q3 2024 |
Q1 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
$974,000 |
USD |
-38% |
Q3 2024 |
Q1 2025 |
| Property, Plant and Equipment, Gross |
$13,556,000 |
USD |
-84% |
Q3 2024 |
Q1 2025 |
| Operating Lease, Liability, Current |
$525,000 |
USD |
14% |
Q3 2024 |
Q1 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$66,000 |
USD |
|
Q3 2024 |
Q1 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$374,000 |
USD |
|
Q3 2024 |
Q1 2025 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.13 |
pure |
0% |
Q3 2024 |
Q1 2025 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$120,000 |
USD |
-53% |
Q3 2024 |
Q1 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Three |
$68,000 |
USD |
|
Q3 2024 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$64,644,000 |
USD |
20% |
Q2 2024 |
FY 2024 |
| Preferred Stock, Shares Authorized |
5,000,000 |
shares |
0% |
Q3 2024 |
Q1 2025 |
| Unrecognized Tax Benefits |
$694,000 |
USD |
28% |
Q2 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year Four |
$11,000 |
USD |
|
Q3 2024 |
Q1 2025 |
| Additional Paid in Capital |
$379,557,000 |
USD |
5.9% |
Q3 2024 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$97,435,000 |
USD |
36% |
Q2 2024 |
FY 2024 |
| Share-based Payment Arrangement, Expense |
$736,000 |
USD |
-190% |
Q3 2024 |
Q1 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
Q1 2025 |